 | • レポートコード：MRC2102QY2722 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の細胞性腫瘍抗体P53市場について種類別（COTI-2、D-12PGJ3、APR-246、ATRN-502、セナーセンナトリウム、MJ-05、MX-225、その他）、用途別（卵巣がん、前立腺がん、脳腫瘍、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・細胞性腫瘍抗体P53市場の概要 ・世界の主要地域別細胞性腫瘍抗体P53市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の細胞性腫瘍抗体P53市場規模2015-2026：種類別（COTI-2、D-12PGJ3、APR-246、ATRN-502、セナーセンナトリウム、MJ-05、MX-225、その他） ・世界の細胞性腫瘍抗体P53市場規模2015-2026：用途別（卵巣がん、前立腺がん、脳腫瘍、その他） ・細胞性腫瘍抗体P53の米国市場規模2015-2020 ・細胞性腫瘍抗体P53のヨーロッパ市場規模2015-2020 ・細胞性腫瘍抗体P53の中国市場規模2015-2020 ・細胞性腫瘍抗体P53の日本市場規模2015-2020 ・細胞性腫瘍抗体P53の東南アジア市場規模2015-2020 ・細胞性腫瘍抗体P53のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・細胞性腫瘍抗体P53の製造コスト分析 ・販売チャネル、流通業者、顧客 ・細胞性腫瘍抗体P53の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Cellular Tumor Antigen p53 Market
The global Cellular Tumor Antigen p53 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Cellular Tumor Antigen p53 Scope and Market Size
The global Cellular Tumor Antigen p53 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cellular Tumor Antigen p53 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Cellular Tumor Antigen p53 market is segmented into
COTI-2
D-12PGJ3
APR-246
ATRN-502
Cenersen Sodium
MJ-05
MX-225
Others
Segment by Application, the Cellular Tumor Antigen p53 market is segmented into
Ovarian Cancer
Prostate Cancer
Brain Cancer
Others
The Cellular Tumor Antigen p53 market is analysed and market size information is provided by regions (countries). Segment by Application, the Cellular Tumor Antigen p53 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cellular Tumor Antigen p53 Market Share Analysis
Cellular Tumor Antigen p53 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cellular Tumor Antigen p53 business, the date to enter into the Cellular Tumor Antigen p53 market, Cellular Tumor Antigen p53 product introduction, recent developments, etc.
The major vendors covered:
Advaxis, Inc.
American Gene Technologies International Inc.
Aprea AB
Cellceutix Corporation
Critical Outcome Technologies Inc.
Eleos Inc.
ORCA Therapeutics B.V.
OSE Pharma SA
PCI Biotech Holding ASA
Quark Pharmaceuticals, Inc.
Stemline Therapeutics, Inc.
Shenzen SiBiono GeneTech Co., Ltd.
SK Biopharmaceuticals Co., Ltd.
Tara Immuno-Oncology Therapeutics LLC
Z53 Therapeutics, LLC
1 Cellular Tumor Antigen p53 Market Overview
1.1 Cellular Tumor Antigen p53 Product Scope
1.2 Cellular Tumor Antigen p53 Segment by Type
1.2.1 Global Cellular Tumor Antigen p53 Sales by Type (2020-2026)
1.2.2 COTI-2
1.2.3 D-12PGJ3
1.2.4 APR-246
1.2.5 ATRN-502
1.2.6 Cenersen Sodium
1.2.7 MJ-05
1.2.8 MX-225
1.2.9 Others
1.3 Cellular Tumor Antigen p53 Segment by Application
1.3.1 Global Cellular Tumor Antigen p53 Sales Comparison by Application (2020-2026)
1.3.2 Ovarian Cancer
1.3.3 Prostate Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Cellular Tumor Antigen p53 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cellular Tumor Antigen p53 Sales Growth Rate (2015-2026)
1.4.2 Global Cellular Tumor Antigen p53 Revenue and Growth Rate (2015-2026)
1.4.3 Global Cellular Tumor Antigen p53 Price Trends (2015-2026)
2 Cellular Tumor Antigen p53 Estimate and Forecast by Region
2.1 Global Cellular Tumor Antigen p53 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cellular Tumor Antigen p53 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cellular Tumor Antigen p53 Sales Market Share by Region (2015-2020)
2.2.2 Global Cellular Tumor Antigen p53 Revenue Market Share by Region (2015-2020)
2.3 Global Cellular Tumor Antigen p53 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cellular Tumor Antigen p53 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cellular Tumor Antigen p53 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
2.4.2 Europe Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
2.4.3 China Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
2.4.4 Japan Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
2.4.6 India Cellular Tumor Antigen p53 Estimates and Projections (2015-2026)
3 Global Cellular Tumor Antigen p53 Competition Landscape by Players
3.1 Global Top Cellular Tumor Antigen p53 Players by Sales (2015-2020)
3.2 Global Top Cellular Tumor Antigen p53 Players by Revenue (2015-2020)
3.3 Global Cellular Tumor Antigen p53 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cellular Tumor Antigen p53 as of 2019)
3.4 Global Cellular Tumor Antigen p53 Average Price by Company (2015-2020)
3.5 Manufacturers Cellular Tumor Antigen p53 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cellular Tumor Antigen p53 Players (Opinion Leaders)
4 Global Cellular Tumor Antigen p53 Market Size by Type
4.1 Global Cellular Tumor Antigen p53 Historic Market Review by Type (2015-2020)
4.1.1 Global Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
4.1.2 Global Cellular Tumor Antigen p53 Revenue Market Share by Type (2015-2020)
4.1.3 Global Cellular Tumor Antigen p53 Price by Type (2015-2020)
4.2 Global Cellular Tumor Antigen p53 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cellular Tumor Antigen p53 Sales Forecast by Type (2021-2026)
4.2.2 Global Cellular Tumor Antigen p53 Revenue Forecast by Type (2021-2026)
4.2.3 Global Cellular Tumor Antigen p53 Price Forecast by Type (2021-2026)
5 Global Cellular Tumor Antigen p53 Market Size by Application
5.1 Global Cellular Tumor Antigen p53 Historic Market Review by Application (2015-2020)
5.1.1 Global Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
5.1.2 Global Cellular Tumor Antigen p53 Revenue Market Share by Application (2015-2020)
5.1.3 Global Cellular Tumor Antigen p53 Price by Application (2015-2020)
5.2 Global Cellular Tumor Antigen p53 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cellular Tumor Antigen p53 Sales Forecast by Application (2021-2026)
5.2.2 Global Cellular Tumor Antigen p53 Revenue Forecast by Application (2021-2026)
5.2.3 Global Cellular Tumor Antigen p53 Price Forecast by Application (2021-2026)
6 United States Cellular Tumor Antigen p53 Market Facts & Figures
6.1 United States Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
6.2 United States Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
6.3 United States Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
7 Europe Cellular Tumor Antigen p53 Market Facts & Figures
7.1 Europe Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
7.2 Europe Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
7.3 Europe Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
8 China Cellular Tumor Antigen p53 Market Facts & Figures
8.1 China Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
8.2 China Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
8.3 China Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
9 Japan Cellular Tumor Antigen p53 Market Facts & Figures
9.1 Japan Cellular Tumor Antigen p53 Sales Market Share by Company (3015-3030)
9.2 Japan Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
9.3 Japan Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
10 Southeast Asia Cellular Tumor Antigen p53 Market Facts & Figures
10.1 Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
11 India Cellular Tumor Antigen p53 Market Facts & Figures
11.1 India Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
11.2 India Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
11.3 India Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cellular Tumor Antigen p53 Business
12.1 Advaxis, Inc.
12.1.1 Advaxis, Inc. Corporation Information
12.1.2 Advaxis, Inc. Business Overview
12.1.3 Advaxis, Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Advaxis, Inc. Cellular Tumor Antigen p53 Products Offered
12.1.5 Advaxis, Inc. Recent Development
12.2 American Gene Technologies International Inc.
12.2.1 American Gene Technologies International Inc. Corporation Information
12.2.2 American Gene Technologies International Inc. Business Overview
12.2.3 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Products Offered
12.2.5 American Gene Technologies International Inc. Recent Development
12.3 Aprea AB
12.3.1 Aprea AB Corporation Information
12.3.2 Aprea AB Business Overview
12.3.3 Aprea AB Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Aprea AB Cellular Tumor Antigen p53 Products Offered
12.3.5 Aprea AB Recent Development
12.4 Cellceutix Corporation
12.4.1 Cellceutix Corporation Corporation Information
12.4.2 Cellceutix Corporation Business Overview
12.4.3 Cellceutix Corporation Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cellceutix Corporation Cellular Tumor Antigen p53 Products Offered
12.4.5 Cellceutix Corporation Recent Development
12.5 Critical Outcome Technologies Inc.
12.5.1 Critical Outcome Technologies Inc. Corporation Information
12.5.2 Critical Outcome Technologies Inc. Business Overview
12.5.3 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Products Offered
12.5.5 Critical Outcome Technologies Inc. Recent Development
12.6 Eleos Inc.
12.6.1 Eleos Inc. Corporation Information
12.6.2 Eleos Inc. Business Overview
12.6.3 Eleos Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eleos Inc. Cellular Tumor Antigen p53 Products Offered
12.6.5 Eleos Inc. Recent Development
12.7 ORCA Therapeutics B.V.
12.7.1 ORCA Therapeutics B.V. Corporation Information
12.7.2 ORCA Therapeutics B.V. Business Overview
12.7.3 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Products Offered
12.7.5 ORCA Therapeutics B.V. Recent Development
12.8 OSE Pharma SA
12.8.1 OSE Pharma SA Corporation Information
12.8.2 OSE Pharma SA Business Overview
12.8.3 OSE Pharma SA Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 OSE Pharma SA Cellular Tumor Antigen p53 Products Offered
12.8.5 OSE Pharma SA Recent Development
12.9 PCI Biotech Holding ASA
12.9.1 PCI Biotech Holding ASA Corporation Information
12.9.2 PCI Biotech Holding ASA Business Overview
12.9.3 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.9.4 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Products Offered
12.9.5 PCI Biotech Holding ASA Recent Development
12.10 Quark Pharmaceuticals, Inc.
12.10.1 Quark Pharmaceuticals, Inc. Corporation Information
12.10.2 Quark Pharmaceuticals, Inc. Business Overview
12.10.3 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Products Offered
12.10.5 Quark Pharmaceuticals, Inc. Recent Development
12.11 Stemline Therapeutics, Inc.
12.11.1 Stemline Therapeutics, Inc. Corporation Information
12.11.2 Stemline Therapeutics, Inc. Business Overview
12.11.3 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Products Offered
12.11.5 Stemline Therapeutics, Inc. Recent Development
12.12 Shenzen SiBiono GeneTech Co., Ltd.
12.12.1 Shenzen SiBiono GeneTech Co., Ltd. Corporation Information
12.12.2 Shenzen SiBiono GeneTech Co., Ltd. Business Overview
12.12.3 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Products Offered
12.12.5 Shenzen SiBiono GeneTech Co., Ltd. Recent Development
12.13 SK Biopharmaceuticals Co., Ltd.
12.13.1 SK Biopharmaceuticals Co., Ltd. Corporation Information
12.13.2 SK Biopharmaceuticals Co., Ltd. Business Overview
12.13.3 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.13.4 SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Products Offered
12.13.5 SK Biopharmaceuticals Co., Ltd. Recent Development
12.14 Tara Immuno-Oncology Therapeutics LLC
12.14.1 Tara Immuno-Oncology Therapeutics LLC Corporation Information
12.14.2 Tara Immuno-Oncology Therapeutics LLC Business Overview
12.14.3 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Products Offered
12.14.5 Tara Immuno-Oncology Therapeutics LLC Recent Development
12.15 Z53 Therapeutics, LLC
12.15.1 Z53 Therapeutics, LLC Corporation Information
12.15.2 Z53 Therapeutics, LLC Business Overview
12.15.3 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Products Offered
12.15.5 Z53 Therapeutics, LLC Recent Development
13 Cellular Tumor Antigen p53 Manufacturing Cost Analysis
13.1 Cellular Tumor Antigen p53 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cellular Tumor Antigen p53
13.4 Cellular Tumor Antigen p53 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cellular Tumor Antigen p53 Distributors List
14.3 Cellular Tumor Antigen p53 Customers
15 Market Dynamics
15.1 Cellular Tumor Antigen p53 Market Trends
15.2 Cellular Tumor Antigen p53 Opportunities and Drivers
15.3 Cellular Tumor Antigen p53 Market Challenges
15.4 Cellular Tumor Antigen p53 Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cellular Tumor Antigen p53 Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Cellular Tumor Antigen p53 Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Cellular Tumor Antigen p53 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cellular Tumor Antigen p53 Sales (K Pcs) by Region (2015-2020)
Table 5. Global Cellular Tumor Antigen p53 Sales Market Share by Region (2015-2020)
Table 6. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cellular Tumor Antigen p53 Revenue Share by Region (2015-2020)
Table 8. Global Cellular Tumor Antigen p53 Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Cellular Tumor Antigen p53 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cellular Tumor Antigen p53 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cellular Tumor Antigen p53 (K Pcs) of Key Companies (2015-2020)
Table 13. Global Cellular Tumor Antigen p53 Sales Share by Company (2015-2020)
Table 14. Global Cellular Tumor Antigen p53 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cellular Tumor Antigen p53 Revenue Share by Company (2015-2020)
Table 16. Global Cellular Tumor Antigen p53 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cellular Tumor Antigen p53 as of 2019)
Table 17. Global Cellular Tumor Antigen p53 Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Cellular Tumor Antigen p53 Manufacturing Sites and Area Served
Table 19. Manufacturers Cellular Tumor Antigen p53 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cellular Tumor Antigen p53 Players
Table 22. Global Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 23. Global Cellular Tumor Antigen p53 Sales Share by Type (2015-2020)
Table 24. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cellular Tumor Antigen p53 Price (K Pcs) by Type (2015-2020)
Table 26. Global Cellular Tumor Antigen p53 Sales Share by Type (2021-2026)
Table 27. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cellular Tumor Antigen p53 Revenue Share by Type (2021-2026)
Table 29. Global Cellular Tumor Antigen p53 Price (K Pcs) by Type (2021-2026)
Table 30. Global Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 31. Global Cellular Tumor Antigen p53 Sales Share by Application (2015-2020)
Table 32. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cellular Tumor Antigen p53 Price (K Pcs) by Application (2015-2020)
Table 34. Global Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2021-2026)
Table 35. Global Cellular Tumor Antigen p53 Sales Share by Application (2021-2026)
Table 36. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cellular Tumor Antigen p53 Revenue Share by Application (2021-2026)
Table 38. Global Cellular Tumor Antigen p53 Price (K Pcs) by Application (2021-2026)
Table 39. United States Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 40. United States Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 41. United States Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 42. United States Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 43. United States Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 44. United States Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
Table 45. Europe Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 47. Europe Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 49. Europe Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 51. China Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 52. China Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 53. China Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 54. China Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 55. China Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 56. China Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
Table 57. Japan Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 59. Japan Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 61. Japan Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
Table 69. India Cellular Tumor Antigen p53 Sales (K Pcs) by Company (2015-2020)
Table 70. India Cellular Tumor Antigen p53 Sales Market Share by Company (2015-2020)
Table 71. India Cellular Tumor Antigen p53 Sales (K Pcs) by Type (2015-2020)
Table 72. India Cellular Tumor Antigen p53 Sales Market Share by Type (2015-2020)
Table 73. India Cellular Tumor Antigen p53 Sales (K Pcs) by Application (2015-2020)
Table 74. India Cellular Tumor Antigen p53 Sales Market Share by Application (2015-2020)
Table 75. Advaxis, Inc. Corporation Information
Table 76. Advaxis, Inc. Description and Business Overview
Table 77. Advaxis, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Advaxis, Inc. Cellular Tumor Antigen p53 Product
Table 79. Advaxis, Inc. Recent Development
Table 80. American Gene Technologies International Inc. Corporation Information
Table 81. American Gene Technologies International Inc. Description and Business Overview
Table 82. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product
Table 84. American Gene Technologies International Inc. Recent Development
Table 85. Aprea AB Corporation Information
Table 86. Aprea AB Description and Business Overview
Table 87. Aprea AB Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Aprea AB Cellular Tumor Antigen p53 Product
Table 89. Aprea AB Recent Development
Table 90. Cellceutix Corporation Corporation Information
Table 91. Cellceutix Corporation Description and Business Overview
Table 92. Cellceutix Corporation Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Cellceutix Corporation Cellular Tumor Antigen p53 Product
Table 94. Cellceutix Corporation Recent Development
Table 95. Critical Outcome Technologies Inc. Corporation Information
Table 96. Critical Outcome Technologies Inc. Description and Business Overview
Table 97. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product
Table 99. Critical Outcome Technologies Inc. Recent Development
Table 100. Eleos Inc. Corporation Information
Table 101. Eleos Inc. Description and Business Overview
Table 102. Eleos Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Eleos Inc. Cellular Tumor Antigen p53 Product
Table 104. Eleos Inc. Recent Development
Table 105. ORCA Therapeutics B.V. Corporation Information
Table 106. ORCA Therapeutics B.V. Description and Business Overview
Table 107. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product
Table 109. ORCA Therapeutics B.V. Recent Development
Table 110. OSE Pharma SA Corporation Information
Table 111. OSE Pharma SA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. OSE Pharma SA Description and Business Overview
Table 113. OSE Pharma SA Cellular Tumor Antigen p53 Product
Table 114. OSE Pharma SA Recent Development
Table 115. PCI Biotech Holding ASA Corporation Information
Table 116. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. PCI Biotech Holding ASA Description and Business Overview
Table 118. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product
Table 119. PCI Biotech Holding ASA Recent Development
Table 120. Quark Pharmaceuticals, Inc. Corporation Information
Table 121. Quark Pharmaceuticals, Inc. Description and Business Overview
Table 122. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product
Table 124. Quark Pharmaceuticals, Inc. Recent Development
Table 125. Stemline Therapeutics, Inc. Corporation Information
Table 126. Stemline Therapeutics, Inc. Description and Business Overview
Table 127. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Product
Table 129. Stemline Therapeutics, Inc. Recent Development
Table 130. Shenzen SiBiono GeneTech Co., Ltd. Corporation Information
Table 131. Shenzen SiBiono GeneTech Co., Ltd. Description and Business Overview
Table 132. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Product
Table 134. Shenzen SiBiono GeneTech Co., Ltd. Recent Development
Table 135. SK Biopharmaceuticals Co., Ltd. Corporation Information
Table 136. SK Biopharmaceuticals Co., Ltd. Description and Business Overview
Table 137. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Product
Table 139. SK Biopharmaceuticals Co., Ltd. Recent Development
Table 140. Tara Immuno-Oncology Therapeutics LLC Corporation Information
Table 141. Tara Immuno-Oncology Therapeutics LLC Description and Business Overview
Table 142. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product
Table 144. Tara Immuno-Oncology Therapeutics LLC Recent Development
Table 145. Z53 Therapeutics, LLC Corporation Information
Table 146. Z53 Therapeutics, LLC Description and Business Overview
Table 147. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product
Table 149. Z53 Therapeutics, LLC Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Cellular Tumor Antigen p53 Distributors List
Table 153. Cellular Tumor Antigen p53 Customers List
Table 154. Cellular Tumor Antigen p53 Market Key Trends
Table 155. Cellular Tumor Antigen p53 Key Opportunities and Drivers
Table 156. Cellular Tumor Antigen p53 Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Cellular Tumor Antigen p53 Product Picture
Figure 2. Global Cellular Tumor Antigen p53 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cellular Tumor Antigen p53 Market Share by Application in 2020 & 2026
Figure 6. Ovarian Cancer Examples
Figure 7. Prostate Cancer Examples
Figure 8. Brain Cancer Examples
Figure 9. Others Examples
Figure 10. Global Cellular Tumor Antigen p53 Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Cellular Tumor Antigen p53 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Cellular Tumor Antigen p53 Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Cellular Tumor Antigen p53 Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Cellular Tumor Antigen p53 Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Cellular Tumor Antigen p53 Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Cellular Tumor Antigen p53 Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Cellular Tumor Antigen p53 Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Cellular Tumor Antigen p53 Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Cellular Tumor Antigen p53 Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Cellular Tumor Antigen p53 Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Cellular Tumor Antigen p53 Players Market Share by Revenue in Cellular Tumor Antigen p53 2015 & 2019
Figure 28. Cellular Tumor Antigen p53 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Cellular Tumor Antigen p53 Revenue Share by Type (2015-2020)
Figure 30. Global Cellular Tumor Antigen p53 Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Cellular Tumor Antigen p53 Revenue Share by Application (2015-2020)
Figure 32. Global Cellular Tumor Antigen p53 Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 34. United States Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 35. Europe Cellular Tumor Antigen p53 Sales Market Share by Company in 2019
Figure 36. Europe Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 37. Europe Cellular Tumor Antigen p53 Sales Market Share by Application in 2019
Figure 38. China Cellular Tumor Antigen p53 Sales Market Share by Company in 2019
Figure 39. China Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 40. China Cellular Tumor Antigen p53 Sales Market Share by Application in 2019
Figure 41. Japan Cellular Tumor Antigen p53 Sales Market Share by Company in 2019
Figure 42. Japan Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 43. Japan Cellular Tumor Antigen p53 Sales Market Share by Application in 2019
Figure 44. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Company in 2019
Figure 45. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 46. Southeast Asia Cellular Tumor Antigen p53 Sales Market Share by Application in 2019
Figure 47. India Cellular Tumor Antigen p53 Sales Market Share by Company in 2019
Figure 48. India Cellular Tumor Antigen p53 Sales Market Share by Type in 2019
Figure 49. India Cellular Tumor Antigen p53 Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Cellular Tumor Antigen p53
Figure 52. Manufacturing Process Analysis of Cellular Tumor Antigen p53
Figure 53. Cellular Tumor Antigen p53 Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
CD抗原がん治療の世界市場レポート2020 Market Analysis and Insights: Global CD Antigen Cancer Therapy Market The global CD Antigen Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global CD Antigen Cancer Therapy Scope and Market Size The global CD An…- セルラーガラスの世界市場レポート2020 Cellular Glass is a superior insulation material. It is characterized by small surface density, high strength, low thermal conductivity, heat resistance, anti-freeze-thaw resistance, low water absorption, no burning, sound absorption, good corrosion resistance and workability, not only widely used i…
- TETRAターミナルの世界市場レポート2020 Market Analysis and Insights: Global TETRA Terminals Market The global TETRA Terminals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global TETRA Terminals Scope and Market Size The global TETRA Terminals market is segmented…
- がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…
- 組織工学における代用皮膚の世界市場レポート2020 Market Analysis and Insights: Global Tissue Engineered Skin Substitutes Market The global Tissue Engineered Skin Substitutes market size is projected to reach US$ 2832.1 million by 2026, from US$ 1620.4 million in 2020, at a CAGR of 9.8% during 2021-2026. Global Tissue Engineered Skin Substitutes Sc…